umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Ten years' experience of enzyme infusion therapy of Norrbottnian (type 3) Gaucher disease.
Umeå University, Faculty of Medicine, Clinical Sciences, Paediatrics.
Show others and affiliations
2006 (English)In: Acta Paediatr, ISSN 0803-5253, Vol. 95, no 3, 312-7 p.Article in journal (Refereed) Published
Abstract [en]

AIM: To study the long-term effects of enzyme replacement therapy on the neurological signs of chronic neuronopathic Gaucher disease and to evaluate some biochemical parameters for monitoring the treatment. METHODS: Eight patients from the Norrbottnian cohort were followed during 10 y of treatment. They were followed with regular clinical observations, biochemical tests and psychometric testing. RESULTS: After the start of treatment, their general well-being improved and was stable during the follow-up. In three of the patients there were some indications of slow neurological deterioration. The mean results of psychometric testing did not decrease. Glucosylceramide and chitotriosidase levels were useful in monitoring the treatment. The chemokine CCL18 also seems to be a useful parameter for future monitoring. CONCLUSIONS: Enzyme replacement therapy seems to slow down further neurological and mental deterioration in mild chronic neuronopathic (type 3) Gaucher disease.

Place, publisher, year, edition, pages
2006. Vol. 95, no 3, 312-7 p.
Keyword [en]
Adolescent, Adult, Biological Markers/blood, Brain Diseases/*etiology, Chemokines; CC/blood, Child; Preschool, Cohort Studies, Dose-Response Relationship; Drug, Drug Administration Schedule, Female, Gaucher Disease/blood/*complications/*drug therapy, Glucosylceramidase/*administration & dosage, Glucosylceramides/blood, Hexosaminidases/blood, Humans, Male, Treatment Outcome
Identifiers
URN: urn:nbn:se:umu:diva-7010PubMedID: 16497642OAI: oai:DiVA.org:umu-7010DiVA: diva2:146681
Available from: 2008-01-12 Created: 2008-01-12 Last updated: 2011-01-11Bibliographically approved

Open Access in DiVA

No full text

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=16497642&dopt=Citation
By organisation
Paediatrics

Search outside of DiVA

GoogleGoogle Scholar

pubmed
urn-nbn

Altmetric score

pubmed
urn-nbn
Total: 36 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf